Status:
RECRUITING
Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
Lead Sponsor:
Dedienne Sante S.A.S.
Collaborating Sponsors:
EVAMED
Conditions:
Degenerative Hip Joint Disease
Post-traumatic Osteoarthritis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty...
Eligibility Criteria
Inclusion
- Patient age \> 18 years at implantation.
- Patient who will undergo, during the study's period of inclusion, a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device (DEDIENNE Santé).
- Patient informed of his/her participation and willing to participate in the study.
- Patient able to read, write and understand French.
Exclusion
- Patient deprived of freedom, under guardianship/curatorship or placed under judicial protection
- Patient unable to follow study procedures.
- Patient who has already been included in the study for a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device.
Key Trial Info
Start Date :
September 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2034
Estimated Enrollment :
747 Patients enrolled
Trial Details
Trial ID
NCT05227924
Start Date
September 21 2021
End Date
September 1 2034
Last Update
August 27 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé de la Châtaigneraie
Beaumont, France, 63110
2
CH de Marmande - CHIC
Marmande, France, 47207
3
Hôpital Privé du Grand Narbonne
Montredon-des-Corbières, France, 11100
4
Polyclinique Grand Sud
Nîmes, France, 30932